TAG, TB CAB, India CAB open letter to Qiagen

Re: Marketing and use of QuantiFERON-TB Gold for active TB in India and high TB burden countries

You can download from here an open letter from Treatment Action Group (TAG), members of the Global TB Community Advisory Board (TB CAB) as well as civil society in India who are concerned about Qiagen’s QuantiFERON-TB Gold being used to detect active TB disease in the private sector (where serology use was rampant and has now been banned). The letter urges the company and its distributors to market the test as the label indicates and take action to stop the unethical, off-label use of the test for active TB.

Supporting documents mentioned in the letter:

1. Download the Lal Path Lab Memo from here.

2. Download the RNTCP Serology Ad from here.


You can download Qiagen's response to the letter from here.

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By Treatment Action Group, TB CAB, India CAB

Published: May 17, 2013, 4:36 p.m.

Last updated: Oct. 19, 2015, 6:30 p.m.

Tags: None

Print Share